119 related articles for article (PubMed ID: 7504770)
1. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate.
Schick BP; Thornton RD
Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770
[TBL] [Abstract][Full Text] [Related]
2. Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288-11 and normal human megakaryocytes.
Schick BP; Jacoby JA
J Cell Physiol; 1995 Oct; 165(1):96-106. PubMed ID: 7559813
[TBL] [Abstract][Full Text] [Related]
3. Regulation of expression of megakaryocyte and platelet proteoglycans.
Schick BP
Stem Cells; 1996; 14 Suppl 1():220-31. PubMed ID: 11012225
[TBL] [Abstract][Full Text] [Related]
4. Proteoglycan synthesis in human erythroleukaemia (HEL) cells.
Schick BP; Senkowski-Richardson S
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):651-8. PubMed ID: 1372801
[TBL] [Abstract][Full Text] [Related]
5. Expression of the serglycin gene in human leukemic cell lines.
Maillet P; Alliel PM; Mitjavila MT; Périn JP; Jollès P; Bonnet F
Leukemia; 1992 Nov; 6(11):1143-7. PubMed ID: 1434796
[TBL] [Abstract][Full Text] [Related]
6. Changes in protein sulfation in human erythroleukemia (HEL), CHRF-288-11, and K562 cells following treatment with dimethyl sulfoxide or phorbol 12-myristate 13-acetate.
Schick BP; Tang RP; Jacoby JA
Arch Biochem Biophys; 1995 Feb; 317(1):191-200. PubMed ID: 7872784
[TBL] [Abstract][Full Text] [Related]
7. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
[TBL] [Abstract][Full Text] [Related]
8. Platelet factor 4 mRNA expression in human erythroleukemic cells: regulation by phorbol esters and certain cytokines.
Hunt P; Hokom MM; Fisher CA; Jacobsen FW; Wiemann B; Martin FH
Exp Hematol; 1991 Sep; 19(8):779-84. PubMed ID: 1868892
[TBL] [Abstract][Full Text] [Related]
9. Promoter regulatory elements and DNase I-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells.
Schick BP; Petrushina I; Brodbeck KC; Castronuevo P
J Biol Chem; 2001 Jul; 276(27):24726-35. PubMed ID: 11333275
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells.
Dai W; Murphy MJ
Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382
[TBL] [Abstract][Full Text] [Related]
12. DNase I hypersensitivity patterns of the serglycin proteoglycan gene in resting and phorbol 12-myristate 13-acetate-stimulated human erythroleukemia (HEL), CHRF 288-11, and HL-60 cells compared with neutrophils and human umbilical vein endothelial cells.
Castronuevo P; Thornton MA; McCarthy LE; Klimas J; Schick BP
J Biol Chem; 2003 Dec; 278(49):48704-12. PubMed ID: 14506241
[TBL] [Abstract][Full Text] [Related]
13. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation.
Wu J; Zhu JQ; Han KK; Zhu DX
Oncogene; 1990 Jun; 5(6):873-7. PubMed ID: 2141686
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
[TBL] [Abstract][Full Text] [Related]
15. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells.
Kujoth GC; Fahl WE
Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179
[TBL] [Abstract][Full Text] [Related]
16. Effect of phorbol myristate acetate on c-myc, beta-actin, and FV gene expression in morphologically recognizable human megakaryocytes: a kinetic analysis employing in situ hybridization.
Gewirtz AM; Shen YM
Exp Hematol; 1990 Sep; 18(8):945-52. PubMed ID: 2201557
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells.
Hong Y; Martin JF; Vainchenker W; Erusalimsky JD
Blood; 1996 Jan; 87(1):123-31. PubMed ID: 8547633
[TBL] [Abstract][Full Text] [Related]
18. PADGEM protein in human erythroleukemia cells.
Yeo E; Furie BC; Furie B
Blood; 1989 Feb; 73(3):722-8. PubMed ID: 2465041
[TBL] [Abstract][Full Text] [Related]
19. Secretion of proteases in serglycin transfected Madin-Darby canine kidney cells.
Zernichow L; Dalen KT; Prydz K; Winberg JO; Kolset SO
FEBS J; 2006 Feb; 273(3):536-47. PubMed ID: 16420477
[TBL] [Abstract][Full Text] [Related]
20. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells.
Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G
Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
